Home › Funds › HAMILTON LANE ADVISORS LLC › HUMA

HAMILTON LANE ADVISORS LLC position in HUMA

HUMACYTE INC · Health Care

HAMILTON LANE ADVISORS LLC reported holding 21,893 shares of HUMA (HUMACYTE INC) in its Q3 2026 13F filing — a position valued at US$11K, representing 0.01% of its reported portfolio and ranking #19 among its reported holdings. HAMILTON LANE ADVISORS LLC has disclosed HUMA holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)21.89K sh
Reported value held$11.33K
Portfolio Weight0.01%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HAMILTON LANE ADVISORS LLC's HUMA position evolved

HAMILTON LANE ADVISORS LLC first disclosed a stake in HUMA in Q3 2023 at 21,893 shares (US$64K). The position peaked in Q3 2024 at 21,893 shares, worth US$119K. Across 12 filings, HAMILTON LANE ADVISORS LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 21,893 shares valued at US$11K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 21.89K $64.15K New
Q4 2023 21.89K $62.18K Hold
Q1 2024 21.89K $68.09K Hold
Q2 2024 21.89K $105.09K Hold
Q3 2024 21.89K $119.10K Hold
Q1 2025 21.89K $37.33K New
Q2 2025 21.89K $45.76K Hold
Q3 2025 21.89K $38.09K Hold
Q4 2025 21.89K $21.03K Hold
Q1 2026 21.89K $13.28K Hold
Q2 2026 21.89K $17.09K Hold
Q3 2026 21.89K $11.33K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HUMA and 13F data

HUMA (HUMACYTE INC) is a Health Care company. 22 other funds we track also report a position in HUMA — the largest reported positions include GREAT POINT PARTNERS LLC (US$2.9M), Lion Point Capital, LP (US$507K), LuminArx Capital Management LP (US$507K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HUMA

All HUMA fund holders →

FAQ

How long has HAMILTON LANE ADVISORS LLC held HUMA?

HAMILTON LANE ADVISORS LLC has disclosed HUMA holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is HAMILTON LANE ADVISORS LLC's current position in HUMA?

As of Q3 2026, HAMILTON LANE ADVISORS LLC holds 21.89K shares of HUMA (HUMACYTE INC), valued at $11.33K, representing 0.01% of its reported portfolio and ranking #19.

Has HAMILTON LANE ADVISORS LLC been buying or selling HUMA?

In the latest 13F filing (Q3 2026), HAMILTON LANE ADVISORS LLC held unchanged its position in HUMA. The position peaked in Q3 2024 at 21.89K shares.

Which other funds hold HUMA?

Other major institutional holders of HUMA include GREAT POINT PARTNERS LLC, Lion Point Capital, LP, LuminArx Capital Management LP, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.